These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1718976)

  • 1. Receptor and antibody interactions of human interleukin-3 characterized by mutational analysis.
    Dorssers LC; Mostert MC; Burger H; Janssen C; Lemson PJ; van Lambalgen R; Wagemaker G; van Leen RW
    J Biol Chem; 1991 Nov; 266(31):21310-7. PubMed ID: 1718976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship study of human interleukin-3. Identification of residues required for biological activity by site-directed mutagenesis.
    Lokker NA; Movva NR; Strittmatter U; Fagg B; Zenke G
    J Biol Chem; 1991 Jun; 266(16):10624-31. PubMed ID: 2037601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A discontinuous eight-amino acid epitope in human interleukin-3 binds the alpha-chain of its receptor.
    Bagley CJ; Phillips J; Cambareri B; Vadas MA; Lopez AF
    J Biol Chem; 1996 Dec; 271(50):31922-8. PubMed ID: 8943237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship study of human interleukin-3: role of the C-terminal region for biological activity.
    Lokker NA; Zenke G; Strittmatter U; Fagg B; Movva NR
    EMBO J; 1991 Aug; 10(8):2125-31. PubMed ID: 1712290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutational analysis of receptor binding sites of interleukin-1 beta: differences in binding of human interleukin-1 beta muteins to human and mouse receptors.
    Grütter MG; van Oostrum J; Priestle JP; Edelmann E; Joss U; Feige U; Vosbeck K; Schmitz A
    Protein Eng; 1994 May; 7(5):663-71. PubMed ID: 8073036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The receptor binding site of human interleukin-3 defined by mutagenesis and molecular modeling.
    Klein BK; Feng Y; McWherter CA; Hood WF; Paik K; McKearn JP
    J Biol Chem; 1997 Sep; 272(36):22630-41. PubMed ID: 9278420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-function relationships of interleukin-3. An analysis based on the function and binding characteristics of a series of interspecies chimera of gibbon and murine interleukin-3.
    Kaushansky K; Shoemaker SG; Broudy VC; Lin NL; Matous JV; Alderman EM; Aghajanian JD; Szklut PJ; VanDyke RE; Pearce MK
    J Clin Invest; 1992 Nov; 90(5):1879-88. PubMed ID: 1385477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies against the human interleukin-11 receptor alpha-chain (IL-11Ralpha) and their use in studies of human mononuclear cells.
    Blanc C; Vusio P; Schleinkofer K; Boisteau O; Pflanz S; Minvielle S; Grötzinger J; Müller-Newen G; Heinrich PC; Jacques Y; Montero-Julian FA
    J Immunol Methods; 2000 Jul; 241(1-2):43-59. PubMed ID: 10915848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the epitopes of neutralizing anti-human IL-3 monoclonal antibodies. Implications for structure-activity relationship.
    Lokker NA; Strittmatter U; Steiner C; Fagg B; Graff P; Kocher HP; Zenke G
    J Immunol; 1991 Feb; 146(3):893-8. PubMed ID: 1703185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single tyrosine residue in the membrane-proximal domain of the granulocyte-macrophage colony-stimulating factor, interleukin (IL)-3, and IL-5 receptor common beta-chain is necessary and sufficient for high affinity binding and signaling by all three ligands.
    Woodcock JM; Bagley CJ; Zacharakis B; Lopez AF
    J Biol Chem; 1996 Oct; 271(42):25999-6006. PubMed ID: 8824238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two contiguous residues in human interleukin-3, Asp21 and Glu22, selectively interact with the alpha- and beta-chains of its receptor and participate in function.
    Barry SC; Bagley CJ; Phillips J; Dottore M; Cambareri B; Moretti P; D'Andrea R; Goodall GJ; Shannon MF; Vadas MA
    J Biol Chem; 1994 Mar; 269(11):8488-92. PubMed ID: 7907592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to interleukin 3 as probes for the interaction of interleukin 3 with its receptor.
    Duronio V; Granleese SR; Clark-Lewis I; Schrader JW; Ziltener HJ
    Cytokine; 1991 Sep; 3(5):414-20. PubMed ID: 1751778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of an interleukin-15alpha receptor-binding site on human interleukin-15.
    Bernard J; Harb C; Mortier E; Quéméner A; Meloen RH; Vermot-Desroches C; Wijdeness J; van Dijken P; Grötzinger J; Slootstra JW; Plet A; Jacques Y
    J Biol Chem; 2004 Jun; 279(23):24313-22. PubMed ID: 15039446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies specific for low-affinity interleukin-3 (IL-3) binding protein AIC2A: evidence that AIC2A is a component of a high-affinity IL-3 receptor.
    Ogorochi T; Hara T; Wang HM; Maruyama K; Miyajima A
    Blood; 1992 Feb; 79(4):895-903. PubMed ID: 1737099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saturation mutagenesis of human interleukin-3.
    Olins PO; Bauer SC; Braford-Goldberg S; Sterbenz K; Polazzi JO; Caparon MH; Klein BK; Easton AM; Paik K; Klover JA
    J Biol Chem; 1995 Oct; 270(40):23754-60. PubMed ID: 7559548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative model building of interleukin-7 using interleukin-4 as a template: a structural hypothesis that displays atypical surface chemistry in helix D important for receptor activation.
    Cosenza L; Rosenbach A; White JV; Murphy JR; Smith T
    Protein Sci; 2000 May; 9(5):916-26. PubMed ID: 10850801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of GM-CSF and IL-3 with the common beta-chain of their receptors.
    Bagley CJ; Woodcock JM; Hercus TR; Shannon MF; Lopez AF
    J Leukoc Biol; 1995 May; 57(5):739-46. PubMed ID: 7759954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of rat anti-mouse interleukin 3 monoclonal antibodies which neutralize bioactivity in vitro.
    Abrams JS; Pearce MK
    J Immunol; 1988 Jan; 140(1):131-7. PubMed ID: 2447167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of primary structural features that define the differential actions of IL-3 and GM-CSF receptors.
    Evans CA; Ariffin S; Pierce A; Whetton AD
    Blood; 2002 Nov; 100(9):3164-74. PubMed ID: 12384414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phage display as a rapid gene expression system: production of bioactive cytokine-phage and generation of neutralizing monoclonal antibodies.
    Gram H; Strittmatter U; Lorenz M; Glück D; Zenke G
    J Immunol Methods; 1993 May; 161(2):169-76. PubMed ID: 8505547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.